EQ - Equillium, Inc.
NASDAQ
->
Healthcare
->
Biotechnology
La Jolla,
United States
Type: Equity
EQ price evolution
EQ
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $11.06 | $11.57 | $23.22 | |
| Short term investments | $22.24 | $20.72 | $17.65 | |
| Net receivables | $5.01 | $5.89 | $5.05 | $3.73 |
| Inventory | ||||
| Total current assets | $33.65 | $41.89 | $42.48 | $49.35 |
| Long term investments | ||||
| Property, plant & equipment | $0.77 | $0.92 | $1.05 | $1.11 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $0.97 | $1.12 | $1.18 | |
| Total investments | $22.24 | $20.72 | $17.65 | |
| Total assets | $34.46 | $42.86 | $43.6 | $50.53 |
| Current liabilities | ||||
| Accounts payable | $3.67 | $4.49 | $2.78 | $4.71 |
| Deferred revenue | $8.43 | $13.36 | $15.73 | |
| Short long term debt | $0.35 | $0.42 | $0.44 | |
| Total current liabilities | $11.06 | $20.17 | $22.21 | $27.57 |
| Long term debt | $0.26 | $0.29 | $0.38 | |
| Total noncurrent liabilities | $0.26 | $0.29 | $0.38 | |
| Total debt | $0.61 | $0.72 | $0.82 | |
| Total liabilities | $11.28 | $20.43 | $22.5 | $27.96 |
| Shareholders' equity | ||||
| Retained earnings | -$188.01 | -$188.01 | -$188.47 | -$185.74 |
| Other shareholder equity | -$0 | $0.25 | $0.42 | $0.14 |
| Total shareholder equity | $22.43 | $21.09 | $22.57 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $23.22 | $59.11 | $50.37 | $23.98 |
| Short term investments | $17.65 | $11.92 | $30.34 | $58.18 |
| Net receivables | $3.73 | $2.84 | ||
| Inventory | ||||
| Total current assets | $49.35 | $76.73 | $83.37 | $85.17 |
| Long term investments | ||||
| Property, plant & equipment | $1.11 | $1.58 | $1.88 | $0.24 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $1.18 | $1.69 | $2.04 | $0.25 |
| Total investments | $17.65 | $11.92 | $30.34 | $58.18 |
| Total assets | $50.53 | $78.42 | $85.41 | $85.43 |
| Current liabilities | ||||
| Accounts payable | $4.71 | $3.98 | $1.23 | $2.77 |
| Deferred revenue | $15.73 | $25.08 | ||
| Short long term debt | $0.44 | $6.12 | $1.8 | $1.67 |
| Total current liabilities | $27.57 | $32.04 | $8.91 | $7.25 |
| Long term debt | $0.38 | $3.24 | $9.98 | $8.28 |
| Total noncurrent liabilities | $0.38 | $14.44 | $9.98 | $8.33 |
| Total debt | $0.82 | $10.19 | $11.79 | $9.94 |
| Total liabilities | $27.96 | $46.48 | $18.9 | $15.57 |
| Shareholders' equity | ||||
| Retained earnings | -$185.74 | -$172.41 | -$109.98 | -$70.92 |
| Other shareholder equity | $0.14 | $0.08 | -$0.14 | -$0.3 |
| Total shareholder equity | $22.57 | $31.94 | $66.5 | $69.85 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $13.85 | $10.69 | $9.21 | |
| Cost of revenue | ||||
| Gross Profit | $13.85 | $10.69 | $9.21 | |
| Operating activities | ||||
| Research & development | $10.81 | $9.74 | $9.18 | |
| Selling, general & administrative | $3.15 | $3.74 | $3.23 | |
| Total operating expenses | $13.95 | $13.48 | $12.41 | |
| Operating income | -$0.1 | -$2.79 | -$3.2 | |
| Income from continuing operations | ||||
| EBIT | $0.47 | -$2.73 | -$2.33 | |
| Income tax expense | $0.02 | |||
| Interest expense | ||||
| Net income | ||||
| Net income | $0.47 | -$2.73 | -$2.34 | |
| Income (for common shares) | $0.47 | -$2.73 | -$2.34 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $36.08 | $15.76 | ||
| Cost of revenue | ||||
| Gross Profit | $36.08 | $15.76 | ||
| Operating activities | ||||
| Research & development | $37.04 | $37.55 | $26.38 | $19.38 |
| Selling, general & administrative | $13.57 | $17.24 | $11.41 | $10.16 |
| Total operating expenses | $50.61 | $77.55 | $37.54 | $29.55 |
| Operating income | -$14.52 | -$61.8 | -$37.54 | -$29.55 |
| Income from continuing operations | ||||
| EBIT | -$12.26 | -$61.38 | -$37.98 | -$28.71 |
| Income tax expense | $0.58 | |||
| Interest expense | $0.49 | $1.05 | $1.07 | $1.1 |
| Net income | ||||
| Net income | -$13.34 | -$62.43 | -$39.05 | -$29.81 |
| Income (for common shares) | -$13.34 | -$62.43 | -$39.05 | -$29.81 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | $0.47 | -$2.73 | -$2.34 | |
| Operating activities | ||||
| Depreciation | $0.04 | $0.03 | $0.03 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $0.95 | $0.97 | $1.05 | |
| Total cash flows from operations | $0.73 | -$8.8 | -$5.66 | |
| Investing activities | ||||
| Capital expenditures | -$0.06 | -$0.02 | -$0.04 | |
| Investments | -$1.29 | -$2.81 | -$5.53 | |
| Total cash flows from investing | $7.82 | -$1.35 | -$2.83 | -$5.57 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.09 | $0.08 | ||
| Net borrowings | ||||
| Total cash flows from financing | $0.09 | $0.09 | $0.08 | |
| Effect of exchange rate | $0.05 | $0.02 | -$0.02 | -$0.01 |
| Change in cash and equivalents | -$7.77 | -$0.51 | -$11.65 | -$11.17 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$13.34 | -$62.43 | -$39.05 | -$29.81 |
| Operating activities | ||||
| Depreciation | $0.13 | $0.12 | $0.07 | $0.04 |
| Business acquisitions & disposals | $0.7 | |||
| Stock-based compensation | $4 | $4.84 | $4.41 | $3.9 |
| Total cash flows from operations | -$21.78 | -$8.73 | -$32.08 | -$24.62 |
| Investing activities | ||||
| Capital expenditures | -$0.05 | -$0.28 | -$0.06 | -$0.2 |
| Investments | -$4.71 | $18.26 | $27.46 | -$18.39 |
| Total cash flows from investing | -$4.76 | $18.68 | $27.41 | -$18.59 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$0.1 | $0.21 | $31.06 | $53.95 |
| Net borrowings | -$9.13 | -$1.43 | ||
| Total cash flows from financing | -$9.23 | -$1.22 | $31.06 | $53.95 |
| Effect of exchange rate | -$0.12 | $0.01 | -$0 | $0.03 |
| Change in cash and equivalents | -$35.89 | $8.74 | $26.38 | $10.76 |
News
Fundamentals
| Market cap | $22.32M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 35.42M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 1.24 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 3.04 |
| Quick ratio | N/A |